Thursday June 27, 2019 13:57

Heathcare Press Release : 02 Nov 2016

Neurim Pharmaceuticals Announces Positive Top-Line Results from Pivotal Phase III Trial of Heathcare—02 Nov 16

Neurim Pharmaceuticals ("Neurim") announced today top-line results from its NEU_CH_7911 Phase III study. PedPRM met the primary efficacy endpoint demonstrating statistically significant improvement in total sleep time (TST) compared to placebo. In

Merck Partners with American Cancer Society to Address Cancer in Women Heathcare—02 Nov 16

Merck, a leading science and technology company, and the American Cancer Society (ACS) today released a report that shows all four of the top causes of cancer deaths in women worldwide are mostly preventable or can often be detected early, when treatment